Navigation Links
BCC Research Publishes a New Report On Global Markets for Rnai Technologies
Date:10/25/2013

Wellesley, MA (PRWEB) October 25, 2013

According to a new technical market research report, RNAi Technologies and Global Markets from BCC Research (http://www.bccresearch.com), the global RNAi research tool and reagent, therapeutic, diagnostic, and agriculture market was valued at almost $210.2 million in 2012 and is expected to reach $220.3 million in 2013. BCC Research projects the market to grow to $290 million by 2018, and register a five-year compound annual growth rate (CAGR) of 5.7 percent from 2013 to 2018.

RNA interference (RNAi) has become an integral part of the biological research, pharmaceutics, diagnostics, and biotechnology industries. Indeed, RNAi provides tremendous benefits to the scientific research community and also has huge potential in therapeutics and diagnostics. New drug candidates are entering clinical trials with encouraging results, sparking renewed interest in RNAi drug delivery research and emerging RNAi-related technology development.

The RNAi research tool and reagent segment is the most established area of the RNAi market. However, the RNAi drug development segment has the greatest potential. According to BCC Research, the biggest obstacle for realizing RNAi’s pharmaceutical potential is RNAi drug delivery. In fact, the technological foundation of many RNAi drug development companies is the RNA delivery intellectual property (IP). The potential market for the drug development segment is worth billions of dollars, but due to the difficulty in drug delivery, there are currently no RNAi drugs in Phase III clinical trials, not to mention approved in the marketplace.

Meanwhile, the RNAi diagnostics segment is the fastest growing segment, and RNAi biotechnology in agriculture is the newest area to be explored. RNAi biotechnology in agriculture is the newest development in the market. This segment, however, may provide a faster return than the RNAi drug development segment because of the lower approval hurdles.

According to BCC Research, ongoing research and development spending, further diversification of RNAi therapeutics companies from human medicine to veterinary medicine and agriculture, and an increasing number of players entering the biomarker development space will drive growth in this market for the foreseeable future.

This report from BCC Research report provides an overview of the current state of the RNAi market, focusing specifically on RNAi research tools and reagents, drug discovery, and diagnostics. It describes the available technologies and the major players currently working in the market, as well as detailed analysis of the competitive environments, including new potential trends in research and product development. This report also identifies the main factors affecting each segment and forecasts market growth, future trends and product development for every major market segment.

The RNAi market is complex, consisting of a number of different segments. This report is intended for business development professionals, entrepreneurs, and other investors who need to fully understand and properly evaluate each segment of the market for RNAi research tools reagents, drug developments, diagnostics, and agriculture. It provides insights into the market position of major companies and presents new opportunities overlooked or less known to the business communities.

Source:http://www.bccresearch.com/pressroom/bio/global-RNAi-research-tool-reagent-therapeutic-diagnostic-agriculture-market-grow-$290-million-2018

Read the full story at http://www.prweb.com/releases/2013/10/prweb11260770.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. SNP Genotyping and Analysis Market is Expected to Reach to USD 9.5 Billion Globally by 2019: Transparency Market Research
2. Ion-exchange Resin Market 2013 Global & China Trend Analysis in a New Research Available at DeepResearchReports.com
3. Global Solid Oxide Fuel Cell Market 2012 – 2016: Worldwide Industry Latest Market Share, Investment Trends, Growth, Size, Trends, Strategy And Forecast Research Report
4. Inflamax Research, Inc. Announces Fully-Integrated Clinical e-Source Data Management Services
5. BioInformatics, LLC New Market Research Report – Social Media and Email Best Practices Guide for Marketing to Life Scientists
6. Dedication Ceremony Held for Louisiana Cancer Research Center in New Orleans
7. McCord Research Hires Former University of Iowa Researcher
8. GIS Market Analysis in US 2012-2016: Worldwide Industry Latest Market Share, Opportunities, Investment Trends, Growth, Size, Trends, Strategy And Forecast Research Report
9. Researchers advance scheme to design seamless integrated circuits etched on graphene
10. Insecticides China News 1307 – New Research Available
11. Harvard researchers, pharma experts offer recommendations to expand access to clinical trial data
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... ... May 24, 2016 , ... Cell therapies for a ... accelerated by research at Worcester Polytechnic Institute (WPI) that yielded a newly patented ... regeneration. , The novel method, developed by WPI faculty members Raymond Page, PhD, ...
(Date:5/24/2016)... (PRWEB) , ... May 24, 2016 , ... Last week, ... for corporate executives and entrepreneurs, held The Future of San Diego Life Science event ... San Diego life science community attended the event with speakers Dr. Rich Heyman, former ...
(Date:5/23/2016)... ... ... blood donations in South Texas and across the nation is growing. , But according to ... are on the decline. In fact, donations across the country are at their lowest point ... the last four years alone. , There is no substitute for blood. , “We want ...
(Date:5/23/2016)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... Board of Directors has approved the payment of a quarterly ... The cash dividend of $0.24 per share ... stockholders of record as of the close of business on ... approval of the Board of Directors and may be adjusted ...
Breaking Biology Technology:
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
Breaking Biology News(10 mins):